Vagal Stimulation for Heart Failure

Author(s):  
Hani N. Sabbah
2017 ◽  
Vol 244 ◽  
pp. 229-234 ◽  
Author(s):  
Gaetano M. De Ferrari ◽  
Craig Stolen ◽  
Anton E. Tuinenburg ◽  
D. Jay Wright ◽  
Josep Brugada ◽  
...  

2014 ◽  
Vol 3 (2) ◽  
pp. 120
Author(s):  
Peter J Schwartz ◽  

An imbalance of the autonomic nervous system, with reduced vagal and increased sympathetic activity, contributes to pathogenesis and clinical deterioration in heart failure (HF). Experimental studies have demonstrated that vagal stimulation (VS) has an antifibrillatory effect that has proved beneficial in animal models of HF. The potential value of chronic VS in man was first investigated with an implantable neuro-stimulator capable of delivering low current pulses with adjustable parameters to stimulate the right vagus. The results of a pilot study and a small multicentre clinical trial of VS in HF patients appeared to show a favourable clinical effect, and feasibility and safety data were encouraging. An ongoing pivotal clinical trial will provide a definitive assessment of the efficacy and usefulness of chronic VS in HF patients.This approach represents a new and exciting possibility for the management of HF that will provide clinicians with a novel tool to modulate non-pharmacologically the autonomic nervous system in patients with moderate-to-advanced HF.


Heart Rhythm ◽  
2009 ◽  
Vol 6 (11) ◽  
pp. S76-S81 ◽  
Author(s):  
Peter J. Schwartz ◽  
Gaetano M. De Ferrari

Author(s):  
Gaetano M. De Ferrari ◽  
Peter J. Schwartz ◽  
Alice Ravera ◽  
Veronica Dusi ◽  
Laura Calvillo

2020 ◽  
Vol 41 (Supplement_1) ◽  
Author(s):  
C Zheng ◽  
M Li ◽  
K Uemura ◽  
T Kawada ◽  
M Inagaki ◽  
...  

Abstract Introduction Chronic right cervical vagal nerve electric stimulation (VS) exerted prognostic benefits in heart failure rats. Exploring the mechanism is significant for clinical application. This study examined the effect of VS on arginine vasopressin (AVP) secretion and drinking behavior in the rats with chronic heart failure. Methods After a week recovery of myocardial infarction (MI), surviving rats after were randomly instrumented to VS group and sham stimulation (SS) group. A drop sensor was used to record real-time fluid consumption. Blood samples were collected weekly from the 3rd week during the 6 weeks treatment. Results Vagal stimulation did not change the daily fluid consumption (Mean ± SE, 76.2 ± 1.1 vs. 77.8 ± 2.1 ml/kg/day, n = 6, P < 0.05). Thirst, which is defined as per drinking volume (PDV), significantly increased during the early weeks after MI (Fig A), while VS significantly suppressed PDV (Fig B is the data of 6th week) by increasing the drinking intervals. The level of plasma AVP was increased to about 2 fold during 6 weeks observation in the SS group, however, VS suppressed this upregulation (Fig C). Conclusion These results suggest that VS may activate vagal afferent components which related to inhibition of AVP secretion and then suppressed the augmentation of thirst. Frequent drinking small volume may benefit for homeostasis in CHF. Abstract P105 Figure. Drinking behavior and AVP


2008 ◽  
Vol 10 (9) ◽  
pp. 884-891 ◽  
Author(s):  
Peter J. Schwartz ◽  
Gaetano M. De Ferrari ◽  
Antonio Sanzo ◽  
Maurizio Landolina ◽  
Roberto Rordorf ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document